Lunit

Lunit is a medical AI software company that focuses on transforming cancer care through advanced deep learning technologies. Its platform is designed to assist healthcare professionals in two primary areas: early cancer detection and precision oncology. For early detection, Lunit’s AI algorithms analyze medical imaging data such as mammograms, chest X-rays, and CT scans to identify suspicious lesions, nodules, or abnormalities that may indicate the presence of cancer. The software is trained on large, diverse datasets and validated through hundreds of peer-reviewed publications, enabling it to flag subtle findings that might be missed by human radiologists. This helps reduce false negatives and speeds up the screening process, making it suitable for population-level screening programs. On the precision oncology side, Lunit provides tools that extract quantitative biomarkers from histopathology slides and radiology images. These biomarkers can predict tumor characteristics, treatment responses, and patient outcomes, supporting oncologists in making personalized treatment decisions. For example, the AI can assess immune cell infiltration, tumor mutational burden, or microsatellite instability from standard tissue slides without additional staining. The software integrates into existing hospital information systems and picture archiving and communication systems (PACS), allowing radiologists and pathologists to use it within their regular workflows. Lunit also partners with pharmaceutical companies and research institutions to accelerate clinical trials by providing automated image analysis endpoints. The company’s products are deployed in over 10,000 customer sites across 65 countries, indicating broad adoption in both developed and emerging markets. Additionally, Lunit o